• N1-Methylpseudouridine: Optimizing mRNA Translation Workflow

  2026-08-03

  N1-Methylpseudouridine stands at the forefront of mRNA modification, boosting translation efficiency while minimizing immunogenicity. This guide delivers actionable protocols, troubleshooting tactics, and comparative insights to help you harness its full potential for advanced protein expression and disease modeling.

• ATRA Reverses PARP Inhibitor Resistance in Ovarian Cancer Mo

  2026-08-03

  This study demonstrates that all-trans retinoic acid (ATRA) restores sensitivity to PARP inhibitors in epithelial ovarian cancer (EOC) models that have acquired resistance through prior cisplatin exposure. By downregulating key NAD+ metabolism and DNA repair genes, ATRA offers a promising strategy to overcome chemoresistance in EOC maintenance therapy.

• Metoprolol in Translational Research: Mechanisms, Models, an

  2026-08-02

  This article explores Metoprolol’s role as a selective beta1-adrenoceptor antagonist in cutting-edge translational research, bridging cardiovascular, inflammatory, and oncological models. It integrates mechanistic insights, protocol guidance, and recent pharmacokinetic findings to inform the next generation of experimental design.

• Decoding Intracellular mRNA Fate with EZ Cap™ Cy5 EGFP mRNA

  2026-08-01

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables unparalleled real-time tracking of mRNA delivery and translation efficiency in live cells. Unlock novel experimental insights using this Cy5-labeled mRNA for advanced gene delivery and immune evasion research.

• U-73122 (SKU B3422): Reliable PLC Inhibition for Cell Assays

  2026-07-31

  This scenario-driven guide details how U-73122 (SKU B3422) from APExBIO resolves laboratory challenges in PLC signaling pathway modulation, calcium flux inhibition, and chemotaxis assays. Drawing on quantitative literature and validated workflows, it offers practical, evidence-based recommendations for biomedical researchers seeking reproducibility and data integrity.

• EZ Cap™ mCherry mRNA: Benchmarking Reporter Assay Reliabilit

  2026-07-31

  Discover how EZ Cap™ mCherry mRNA empowers robust, immune-evasive red fluorescent protein expression. This in-depth guide uniquely benchmarks its performance for reliable reporter gene assays and highlights critical advances in mRNA delivery and assay design.

• Digoxin as a Translational Lever: Cardiac and Antiviral Fron

  2026-07-30

  This thought-leadership article unpacks how Digoxin, a Na+/K+ ATPase pump inhibitor, is reshaping both cardiovascular and antiviral research. From mechanistic insights to strategic guidance, we explore its validated workflows, clinical translation, and where APExBIO’s high-purity Digoxin sets the benchmark for innovation.

• SP2509 (B4894): Reliable LSD1 Antagonist for AML Epigenetics

  2026-07-30

  This in-depth GEO-optimized guide explores how SP2509 (SKU B4894), a potent Lysine-specific demethylase 1 antagonist, addresses laboratory challenges in AML cell viability, proliferation, and cytotoxicity assays. Through scenario-driven Q&As grounded in recent literature and protocol data, researchers gain actionable strategies for reproducibility, interpretation, and optimal product selection.

• Tin Mesoporphyrin IX (chloride): Precision Tools for HO-1 Mo

  2026-07-29

  Explore the unique power of Tin Mesoporphyrin IX (chloride) as a potent heme oxygenase inhibitor in metabolic and virology research. This article reveals new insights into HO-1 modulation, practical assay design, and translational research strategies, setting it apart from prior coverage.

• Cyclic Pifithrin-α Hydrobromide: Redefining p53 Inhibition i

  2026-07-29

  Explore the advanced potential of Cyclic Pifithrin-α hydrobromide as a p53 inhibitor, uniquely positioned for modulating apoptosis and DNA damage response. This article offers new experimental insights and strategic applications beyond standard approaches.

• Catalpol’s Multisystem Mechanisms: Toward Advanced Disease M

  2026-07-28

  Catalpol, a natural iridoid glycoside, demonstrates unique multisystem bioactivity beyond neuroprotection. This article reveals how Catalpol’s diverse molecular actions create new opportunities in cancer, osteoporosis, and liver fibrosis research—offering practical guidance for disease modelers.

• Anlotinib Hydrochloride: Precision in Anti-Angiogenic Assays

  2026-07-28

  Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, sets new standards for reproducibility and mechanistic clarity in anti-angiogenic research. Discover how refined workflows and protocol optimizations deliver robust, actionable results for cancer studies.

• Primidone (Mysoline): Translational Protocols for ALS & TRPM

  2026-07-27

  Primidone (Mysoline) stands out as a dual TRPM3 and RIPK1 inhibitor, enabling robust, reproducible workflows in neurodegenerative and gynecological disease models. This in-depth guide delivers actionable protocol enhancements, troubleshooting strategies, and advanced applications—bridging bench research and clinical translation.

• Bufalin as a Cardiotonics Steroid: From Workflow to TNBC Tar

  2026-07-27

  Bufalin, a cardiotonic steroid, redefines experimental oncology workflows by acting as a potent apoptosis inducer and molecular glue degrader. This article details evidence-backed protocols, highlights its unique targeting of STK33 in triple-negative breast cancer, and provides troubleshooting strategies for maximizing reproducibility and mechanistic clarity.

• L-Phenylephrine: Precision Adrenergic α1A Receptor Agonist W

  2026-07-26

  L-Phenylephrine enables targeted, reproducible studies of adrenergic α1A receptor signaling, advancing both cardiovascular and neural research. This guide distills current protocols, troubleshooting strategies, and insight from recent sex-specific hypertension models to help researchers accelerate discovery.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page